Healthy volunteers test new dissolvable version of FA drug
NCT ID NCT07297199
First seen Jan 04, 2026 · Last updated May 08, 2026 · Updated 24 times
Summary
This study tests whether a new tablet form of the drug omaveloxolone (BIIB141) that dissolves in liquid works the same in the body as the current capsule form. The study involves 70 healthy adults who will take both forms at different times. The goal is to see if the liquid tablet is a good option for people who have trouble swallowing capsules. There is no direct treatment benefit for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Trialmed formerly PPD, Austin Clinical Research Unit
RECRUITINGAustin, Texas, 78744, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.